Budget Amount *help |
¥25,090,000 (Direct Cost: ¥19,300,000、Indirect Cost: ¥5,790,000)
Fiscal Year 2012: ¥8,060,000 (Direct Cost: ¥6,200,000、Indirect Cost: ¥1,860,000)
Fiscal Year 2011: ¥8,060,000 (Direct Cost: ¥6,200,000、Indirect Cost: ¥1,860,000)
Fiscal Year 2010: ¥8,970,000 (Direct Cost: ¥6,900,000、Indirect Cost: ¥2,070,000)
|
Research Abstract |
We identified PPFIBP1-ALK in inflammatory myofibroblastic tumor and TPM3-ALK and EML4-ALK in renal cell carcinoma. In lymphoma, we found SQSTM1-ALK. KLC1-ALK was identified from a formalin-fixed paraffin-embedded (FFPE) tissue by RACE optimized for FFPE. We established a unique system for identification of fusion genes based on histopathological methods, and identified 4 ROS1 and 2 RET novel fusion genes. We also proposed a new entity of low-grade B-cell lymphoma, which was characterized by IRF4 rearrangement
|